Chris Weiser

Chris is a Senior Counsel in Sanofi’s US Market Access legal group where he counsels on government price reporting, drug price transparency and general market access concerns. Previously, Chris held roles at the U.S. Department of Health and Human Services (HHS), first working on health insurance reform and regulation at the Center for Consumer Information and Insurance Oversight (CCIIO) and later on pharmaceutical and health insurance oversight with the Office of Inspector General. Chris received his JD and MPH from The George Washington University.